behavior/neurological
| N |
• normal pain sensitivity and response
|
immune system
| N |
• normal development and responses
|
|
• delayed day of onset
• shorter period of clinical score equal to or greater than 2
• improved clinical outcome at end of experiment compared to peak
• reduced weight loss during acute phase
• no demyelination in spinal cord
• reduced spinal cord axon degeneration
• normal day of peak disease and maximum clinical score at peak
|
nervous system
| N |
• normal brain white and gray matter
• normal spinal cord morphology
• normal numbers of oligodendrocyte precursor cells (OPCs) and oligodendrocytes in spinal cord
|


Analysis Tools